TLR4 as receptor for HMGB1-mediated acute lung injury after liver ischemia/reperfusion injury

Laboratory Investigation

Volumn 93, Issue 7, 2013, Pages 792-800

  Yang, Zhongwei ^a   Deng, Yuxiao ^a   Su, Diansan ^a   Tian, Jie ^a   Gao, Yuan ^a   He, Zhengyu ^a   Wang, Xiangrui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

acute lung injury; AP 1; HMGB1; liver I R Injury; p38MAPK; TLR4

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HIGH MOBILITY GROUP B1 PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SHORT HAIRPIN RNA; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; CONTROLLED STUDY; GAS EXCHANGE; GEL MOBILITY SHIFT ASSAY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; LUNG FUNCTION; LUNG PARENCHYMA; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84879655800     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.66     Document Type: Article

References (45)

1. Hong SK, Hwang S, Lee SG, et al. Pulmonary complications following adult liver transplantation. Transplant Proc 2006;38:2979-2981. (Pubitemid 44737979)
2. Bozbas SS, Eyuboglu FO, Ozturk Ergur F, et al. Pulmonary complications and mortality after liver transplant. Exp Clin transplant 2008;6:264-270.
3. Glasgow SC, Ramachandran S, Csontos KA, et al. Interleukin-1beta is prominent in the early pulmonary inflammatory response after hepatic injury. Surgery 2005;138:64-70. (Pubitemid 40933773)
4. Franco-Gou R, Rosello-Catafau J, Peralta C. Protection against lung damage in reduced-size liver transplantation. Crit Care Med 2006;34:1506-1513.
5. Hirsch J, Niemann CU, Hansen KC, et al. Alterations in the proteome of pulmonary alveolar type II cells in the rat after hepatic ischemia-reperfusion. Crit Care Med 2008;36:1846-1854.
6. Saidi RF, Chang J, Brooks S, et al. Ischemic preconditioning and intermittent clamping increase the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Transplant Proc 2007;39: 3010-3014. (Pubitemid 350251518)
7. Choi S, Noh J, Hirose R, et al. Mild hypothermia provides significant protection against ischemia/reperfusion injury in livers of obese and lean rats. Ann Surg 2005;241:470-476. (Pubitemid 40299724)
8. Lotze MT, Zeh HJ, Rubartelli A, et al. The grateful dead: damageassociated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 2007;220:60-81. (Pubitemid 350045579)
9. Nadatani Y, Watanabe T, Tanigawa T, et al. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal antiinflammatory drugs through toll-like receptor 4. Am J Pathol 2012;181:98-110.
10. Ogawa EN, Ishizaka A, Tasaka S, et al. Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury. Am J Respir Crit Care Med 2006;174:400-407. (Pubitemid 44223120)
11. Kim JY, Park JS, Strassheim D, et al. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 2005;288:L958-965. (Pubitemid 40547924)
12. Hagiwara S, Iwasaka H, Hasegawa A, et al. Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxininduced acute lung injury in a rat model. Crit Care Med 2008;36: 2407-2413.
13. Hori O, Brett J, Slattery T, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995;270:25752-25761.
14. Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004;279:7370-7377. (Pubitemid 38294612)
15. Wang C, Deng L, Hong M, et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001;412:346-351. (Pubitemid 32694385)
16. Sato S, Sanjo H, Takeda K, et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 2005;6: 1087-1095. (Pubitemid 41541786)
17. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007;369:1553-1564. (Pubitemid 46670280)
18. Abraham E, Carmody A, Shenkar R, Arcaroli J. Neutrophils as early immunologic effectors in hemorrhage-or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2000;279:L1137-1145. (Pubitemid 32009500)
19. Andonegui G, Bonder CS, Green F, et al. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest 2003;111:1011-1020. (Pubitemid 36397477)
20. Guillot L, Medjane S, Le-Barillec K, et al. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem 2004;279:2712-2718. (Pubitemid 38114260)
21. Sha Q, Truong-Tran AQ, Plitt JR, et al. Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 2004;31:358-364. (Pubitemid 39180307)
22. He Z, Zhu Y, Jiang H. Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study. Respir Res 2009;10:126.
23. Tian J, Wang Y, He Z, et al. Hydroxyethyl starch (130 kD) inhibits Tolllike receptor 4 signaling pathways in rat lungs challenged with lipopolysaccharide. Anesth Analg 2011;113:112-119.
24. He Z, Gao Y, Deng Y, et al. Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway. PLoS One 2012;7:e35926.
25. Jeyaseelan S, Chu HW, Young SK, et al. Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury. Infect Immun 2005;73:1754-1763. (Pubitemid 40470764)
26. Lv T, Shen X, Shi Y, et al. TLR4 is essential in acute lung injury induced by unresuscitated hemorrhagic shock. J Trauma 2009;66:124-131.
27. Togbe D, Schnyder-Candrian S, Schnyder B, et al. TLR4 gene dosage contributes to endotoxin-induced acute respiratory inflammation. J Leukocyte Biol 2006;80:451-457. (Pubitemid 44835777)
28. Yamamoto T, Ono T, Ito T, et al. Hemoperfusion with a high-mobility group box 1 adsorption column can prevent the occurrence of hepatic ischemia-reperfusion injury in rats. Crit Care Med 2010;38: 879-885.
29. Saidi RF, Chang J, Verb S, et al. The effect of methylprednisolone on warm ischemia-reperfusion injury in the liver. Am J Surg 2007; 193:345-347, discussion 347-348.
30. Takeuchi D, Yoshidome H, Kurosawa H, et al. Interleukin-18 exacerbates pulmonary injury after hepatic ischemia/reperfusion in mice. J Surg Res 2010;158:87-93.
31. Ben DF, Yu XY, Ji GY, et al. TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion. J Surg Res 2012;174:326-333.
32. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251. (Pubitemid 29329996)
33. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-195. (Pubitemid 34773774)
34. Tsung A, Klune JR, Zhang X, et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007;204:2913-2923. (Pubitemid 350179560)
35. Dhupar R, Klune JR, Evankovich J, et al. Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injury. Shock 2011;35:293-301.
36. Lu B, Nakamura T, Inouye K, et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 2012;488:670-674.
37. Lamkanfi M, Sarkar A, Vande Walle L, et al. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol 2010; 185:4385-4392.
38. Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Ann Rev Immunol 2011;29:139-162.
39. Yang H, Wang H, Czura CJ, et al. The cytokine activity of HMGB1. J Leukocyte Biol 2005;78:1-8. (Pubitemid 40979937)
40. Barrenschee M, Lex D, Uhlig S. Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs. PLoS One 2010;5:e13889.
41. Wolfson RK, Chiang ET, Garcia JG. HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption. Microvasc Res 2011;81:189-197.
42. Yang H, Hreggvidsdottir HS, Palmblad K, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 2010;107: 11942-11947.
43. Dobrovolskaia MA, Medvedev AE, Thomas KE, et al. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR 'homotolerance' versus 'heterotolerance' on NF-kappa B signaling pathway components. J Immunol 2003;170:508-519. (Pubitemid 36026178)
44. Wang F, Xia ZF, Chen XL, et al. Angiotensin II type-1 receptor antagonist attenuates LPS-induced acute lung injury. Cytokine 2009;48:246-253.
45. Arumugam TV, Okun E, Tang SC, et al. Toll-like receptors in ischemiareperfusion injury. Shock 2009;32:4-16. Foundation Medicine